JP2024530926A - 低アレルゲン性ピーナッツアレルゲン、その製造方法、及びその使用 - Google Patents

低アレルゲン性ピーナッツアレルゲン、その製造方法、及びその使用 Download PDF

Info

Publication number
JP2024530926A
JP2024530926A JP2024506789A JP2024506789A JP2024530926A JP 2024530926 A JP2024530926 A JP 2024530926A JP 2024506789 A JP2024506789 A JP 2024506789A JP 2024506789 A JP2024506789 A JP 2024506789A JP 2024530926 A JP2024530926 A JP 2024530926A
Authority
JP
Japan
Prior art keywords
seq
recombinant
arahl
mutant polypeptide
ara
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024506789A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024530926A5 (https=
Inventor
オフラン、ヤナイ
デイビッド、モシェ ベン
ガーバー、オーリー マーク
キロス、シー ナフタリー
ディアマント、ギル
コーヘン、アルモグ ブレグマン
コーマン、マアヤン
チュプリン、アンナ
ソレク、ゾハル ビロン
シュラムコビッチ、リオール ローゼンフェルド
ロテム、エタイ
ガット、ヤイール
Original Assignee
ウッコ インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ウッコ インコーポレイテッド filed Critical ウッコ インコーポレイテッド
Publication of JP2024530926A publication Critical patent/JP2024530926A/ja
Publication of JP2024530926A5 publication Critical patent/JP2024530926A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/16Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from plants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/35Allergens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/30Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP2024506789A 2021-08-03 2022-08-02 低アレルゲン性ピーナッツアレルゲン、その製造方法、及びその使用 Pending JP2024530926A (ja)

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
US202163228604P 2021-08-03 2021-08-03
US202163228606P 2021-08-03 2021-08-03
US63/228,604 2021-08-03
US63/228,606 2021-08-03
US202163284108P 2021-11-30 2021-11-30
US63/284,108 2021-11-30
US202163292441P 2021-12-22 2021-12-22
US63/292,441 2021-12-22
US202263311117P 2022-02-17 2022-02-17
US63/311,117 2022-02-17
US202263319393P 2022-03-14 2022-03-14
US202263319394P 2022-03-14 2022-03-14
US63/319,393 2022-03-14
US63/319,394 2022-03-14
PCT/IB2022/057144 WO2023012652A2 (en) 2021-08-03 2022-08-02 Hypoallergenic peanut allergens, production and use thereof

Publications (2)

Publication Number Publication Date
JP2024530926A true JP2024530926A (ja) 2024-08-27
JP2024530926A5 JP2024530926A5 (https=) 2025-07-28

Family

ID=85155450

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024506789A Pending JP2024530926A (ja) 2021-08-03 2022-08-02 低アレルゲン性ピーナッツアレルゲン、その製造方法、及びその使用

Country Status (6)

Country Link
US (2) US20240390485A1 (https=)
EP (1) EP4380957A4 (https=)
JP (1) JP2024530926A (https=)
AU (1) AU2022323847A1 (https=)
CA (1) CA3226900A1 (https=)
WO (1) WO2023012652A2 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2024224738A1 (en) * 2023-02-23 2025-09-18 The General Hospital Corporation, D/B/A Massachusetts General Hospital Mutant ara h 2 and ara h 6 proteins and uses thereof
WO2024256749A1 (en) 2023-06-12 2024-12-19 Desentum Oy Hypoallergenic variants of major peanut allergen, ara h 2
WO2026080920A1 (en) 2024-10-13 2026-04-16 Ukko Inc. Mrna vaccine for peanut allergy treatment

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002306850A1 (en) * 2001-03-16 2002-10-03 Panacea Pharmaceuticals Methods and reagents for decreasing clinical reaction to allergy
US8057800B2 (en) * 2004-06-10 2011-11-15 Circassia Limited Immunointeractive molecules and uses thereof
EP2664624A1 (en) * 2012-05-15 2013-11-20 Biomay Ag Allergen variants
US20200124615A1 (en) * 2016-12-29 2020-04-23 Ukko Inc. Methods for identifying and de-epitoping allergenic polypeptides
EP3793595A1 (en) * 2018-05-15 2021-03-24 Immunomic Therapeutics, Inc. Improved lamp constructs comprising allergens

Also Published As

Publication number Publication date
AU2022323847A1 (en) 2024-02-15
WO2023012652A2 (en) 2023-02-09
EP4380957A4 (en) 2025-09-03
CA3226900A1 (en) 2023-02-09
US20240117020A1 (en) 2024-04-11
WO2023012652A3 (en) 2023-04-06
US20240390485A1 (en) 2024-11-28
EP4380957A2 (en) 2024-06-12

Similar Documents

Publication Publication Date Title
EP2882453B1 (en) Anti-dengue virus antibodies and uses thereof
JP2024530926A (ja) 低アレルゲン性ピーナッツアレルゲン、その製造方法、及びその使用
AU2015217149B2 (en) Novel full spectrum anti-dengue antibody
Asturias et al. Engineering of major house dust mite allergens Der p 1 and Der p 2 for allergen‐specific immunotherapy
Yermakova et al. Sub-domains of ricin’s B subunit as targets of toxin neutralizing and non-neutralizing monoclonal antibodies
TR201812060T4 (tr) Hipoalerjen.
Van Vaerenbergh et al. IgE recognition of chimeric isoforms of the honeybee (Apis mellifera) venom allergen Api m 10 evaluated by protein array technology
Kosztyu et al. Proteins mimicking epitope of HIV-1 virus neutralizing antibody induce virus-neutralizing sera in mice
Levin et al. Phl p 1–specific human monoclonal IgE and design of a hypoallergenic group 1 grass pollen allergen fragment
Shafaghi et al. A new candidate epitope-based vaccine against PspA PhtD of Streptococcus pneumoniae: a computational experimental approach
Nilsson et al. In vitro evolution of allergy vaccine candidates, with maintained structure, but reduced B cell and T cell activation capacity
CN117979981A (zh) 低过敏原性的花生过敏原、其产生及其用途
JP2025538106A (ja) ピーナッツに対する脱感作を誘導するための組成物及び方法
CN119039430B (zh) 靶向结核分枝杆菌MctB的保护性单克隆抗体及制备方法和应用
CN118930645B (zh) 靶向结核分枝杆菌OmpA的保护性单克隆抗体及制备方法和应用
US20250206812A1 (en) Single domain antibodies against bee venom epitopes
US20240400692A1 (en) Celiac disease epitopes
WO2013104901A2 (en) Novel therapies
CN110938150B (zh) E型肉毒毒素重组l-hn抗原的制备方法及其应用
EP2281836B9 (en) Hybrid proteins from Parietaria judaica major allergens and uses thereof
Nilsson et al. In Vitro Evolution of Allergy Vaccine Candidates, with Maintained
HK1210054B (en) Anti-dengue virus antibodies and uses thereof

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250717

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250717